Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Expert Opinion on Pharmacotherapy
|
May 31, 2006
Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina
Kim Fox
Nature Reviews. Cardiology
|
May 27, 2016
Heart rate reduction in coronary artery disease and heart failure
Roberto Ferrari, Kim Fox
Drugs
|
March 12, 2009
Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story
Roberto Ferrari, Kim Fox
Advances in Cardiology
|
August 29, 2006
Heart rate: a risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing
Gaetano Antonio Lanza, Kim Fox, Filippo Crea
European Heart Journal
|
August 15, 2006
Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?
Kim Fox, Roberto Ferrari, Salim Yusuf, et al.
Circulation
|
February 20, 2003
Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial
Jeffrey S Borer, Kim Fox, Patrice Jaillon, et al.
American Heart Journal
|
October 31, 2006
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study
Kim Fox, Roberto Ferrari, Michal Tendera, et al.
Lancet (London, England)
|
September 2, 2008
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Kim Fox, Ian Ford, P Gabriel Steg, et al.
European Heart Journal
|
September 12, 2018
Can we remove scar and fibrosis from adult human myocardium?
Ali Vazir, Kim Fox, Joseph Westaby, et al.
European Heart Journal
|
October 11, 2005
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina
Jean-Claude Tardif, Ian Ford, Michal Tendera, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Expert Opinion on Pharmacotherapy
|
May 31, 2006
Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina
Kim Fox
Nature Reviews. Cardiology
|
May 27, 2016
Heart rate reduction in coronary artery disease and heart failure
Roberto Ferrari, Kim Fox
Drugs
|
March 12, 2009
Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story
Roberto Ferrari, Kim Fox
Advances in Cardiology
|
August 29, 2006
Heart rate: a risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing
Gaetano Antonio Lanza, Kim Fox, Filippo Crea
European Heart Journal
|
August 15, 2006
Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?
Kim Fox, Roberto Ferrari, Salim Yusuf, et al.
Circulation
|
February 20, 2003
Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial
Jeffrey S Borer, Kim Fox, Patrice Jaillon, et al.
American Heart Journal
|
October 31, 2006
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study
Kim Fox, Roberto Ferrari, Michal Tendera, et al.
Lancet (London, England)
|
September 2, 2008
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Kim Fox, Ian Ford, P Gabriel Steg, et al.
European Heart Journal
|
September 12, 2018
Can we remove scar and fibrosis from adult human myocardium?
Ali Vazir, Kim Fox, Joseph Westaby, et al.
European Heart Journal
|
October 11, 2005
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina
Jean-Claude Tardif, Ian Ford, Michal Tendera, et al.
Page
of 7